Impact of routine C-peptide screening in individuals with a clinician diagnosis of type 1 diabetes

被引：0
|
作者：
Foteinopoulou, E. [1 ]
Clarke, C. [1 ]
Pattenden, R. [1 ]
McKnight, J. [1 ]
Strachan, M. W. J. [1 ]
机构：
[1] Western Gen Hosp, Edinburgh, Midlothian, Scotland
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
302
引用
收藏
页码：S152 / S153
页数：2
相关论文
共 50 条
  • [31] A1C for Screening and Diagnosis of Type 2 Diabetes in Routine Clinical Practice
    Lu, Zhong X.
    Walker, Karen Z.
    O'Dea, Kerin
    Sikaris, Ken A.
    Shaw, Jonathan E.
    DIABETES CARE, 2010, 33 (04) : 817 - 819
  • [32] Long duration diabetes is associated with a lower C-peptide concentration and response to aerobic exercise in individuals with type 1 diabetes
    Pitt, J. P.
    McCarthy, O.
    Moser, O.
    Eckstein, M. L.
    Deere, R.
    Bain, S. C.
    Churm, R.
    Dunseath, G. J.
    Jones, C.
    Bracken, R. M.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S198 - S199
  • [33] Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications
    Jeyam, Anita
    Colhoun, Helen
    McGurnaghan, Stuart
    Blackbourn, Luke
    McDonald, Timothy J.
    Palmer, Colin N. A.
    McKnight, John A.
    Strachan, Mark W. J.
    Patrick, Alan W.
    Chalmers, John
    Lindsay, Robert S.
    Petrie, John R.
    Thekkepat, Sandeep
    Collier, Andrew
    MacRury, Sandra
    McKeigue, Paul M.
    DIABETES CARE, 2021, 44 (02) : 390 - 398
  • [34] Proinsulin over the course of one year post Type 1 diabetes diagnosis: ER stress, proinsulin to c-peptide ratio, and the change in c-peptide
    Freese, Jurhee
    Al-Rawi, Rawan
    Choate, Heather
    Martin, Alexandra
    Lunsford, Alison
    Mick, Gail
    McCormick, Kenneth
    HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 166 - 166
  • [35] RESIDUAL SECRETION OF C-PEPTIDE IN TYPE 1 DIABETES MELLITUS: WHAT IS ITS METABOLIC IMPACT?
    Lopes, V.
    Sousa, M.
    Lopes, S.
    Santos, M.
    Matos, C.
    Alves, M.
    Monteiro, A.
    Fernandes, V.
    Lages, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A83 - A83
  • [36] C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective
    Maddaloni, Ernesto
    Bolli, Geremia B.
    Frier, Brian M.
    Little, Randie R.
    Leslie, Richard D.
    Pozzilli, Paolo
    Buzzetti, Raffaela
    DIABETES OBESITY & METABOLISM, 2022, 24 (10): : 1912 - 1926
  • [37] Mortality 15 years after diagnosis of type 1 and type 2 diabetes in adults, with diabetes type defined by autoimmunity and C-peptide
    Thunander, M.
    Landin-Olsson, M.
    Ekstrom, H.
    Holmberg, S.
    DIABETOLOGIA, 2016, 59 : S137 - S137
  • [38] Anemia is inversely associated with serum C-peptide concentrations in individuals with type 2 diabetes
    Chung, Jin Ook
    Park, Seon-Young
    Cho, Dong Hyeok
    Chung, Dong Jin
    Chung, Min Young
    MEDICINE, 2018, 97 (32)
  • [39] Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide
    Sima, AAF
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 220 (1-2) : 133 - 136
  • [40] FASTING PLASMA C-PEPTIDE, GLUCAGON STIMULATED PLASMA C-PEPTIDE, AND URINARY C-PEPTIDE IN RELATION TO CLINICAL TYPE OF DIABETES
    GJESSING, HJ
    MATZEN, LE
    FABER, OK
    FROLAND, A
    DIABETOLOGIA, 1989, 32 (05) : 305 - 311
12345